108 related articles for article (PubMed ID: 19806788)
1. Expression and mutation analysis of TIG1 (tazarotene-induced gene 1) in human gastric cancer.
Son MS; Kang MJ; Park HC; Chi SG; Kim YH
Oncol Res; 2009; 17(11-12):571-80. PubMed ID: 19806788
[TBL] [Abstract][Full Text] [Related]
2. Hypermethylation and silencing of the putative tumor suppressor Tazarotene-induced gene 1 in human cancers.
Youssef EM; Chen XQ; Higuchi E; Kondo Y; Garcia-Manero G; Lotan R; Issa JP
Cancer Res; 2004 Apr; 64(7):2411-7. PubMed ID: 15059893
[TBL] [Abstract][Full Text] [Related]
3. DNA methylation of genes linked with retinoid signaling in gastric carcinoma: expression of the retinoid acid receptor beta, cellular retinol-binding protein 1, and tazarotene-induced gene 1 genes is associated with DNA methylation.
Shutoh M; Oue N; Aung PP; Noguchi T; Kuraoka K; Nakayama H; Kawahara K; Yasui W
Cancer; 2005 Oct; 104(8):1609-19. PubMed ID: 16134180
[TBL] [Abstract][Full Text] [Related]
4. Silencing of the retinoid response gene TIG1 by promoter hypermethylation in nasopharyngeal carcinoma.
Kwong J; Lo KW; Chow LS; Chan FL; To KF; Huang DP
Int J Cancer; 2005 Jan; 113(3):386-92. PubMed ID: 15455391
[TBL] [Abstract][Full Text] [Related]
5. Frequent epigenetic inactivation of RASSF1A by aberrant promoter hypermethylation in human gastric adenocarcinoma.
Byun DS; Lee MG; Chae KS; Ryu BG; Chi SG
Cancer Res; 2001 Oct; 61(19):7034-8. PubMed ID: 11585730
[TBL] [Abstract][Full Text] [Related]
6. Hypermethylation of XIAP-associated factor 1, a putative tumor suppressor gene from the 17p13.2 locus, in human gastric adenocarcinomas.
Byun DS; Cho K; Ryu BK; Lee MG; Kang MJ; Kim HR; Chi SG
Cancer Res; 2003 Nov; 63(21):7068-75. PubMed ID: 14612497
[TBL] [Abstract][Full Text] [Related]
7. Tissue factor pathway inhibitor 2 (TFPI2) is frequently silenced by aberrant promoter hypermethylation in gastric cancer.
Takada H; Wakabayashi N; Dohi O; Yasui K; Sakakura C; Mitsufuji S; Taniwaki M; Yoshikawa T
Cancer Genet Cytogenet; 2010 Feb; 197(1):16-24. PubMed ID: 20113832
[TBL] [Abstract][Full Text] [Related]
8. Promoter hypermethylation of MGMT is associated with protein loss in gastric carcinoma.
Oue N; Shigeishi H; Kuniyasu H; Yokozaki H; Kuraoka K; Ito R; Yasui W
Int J Cancer; 2001 Sep; 93(6):805-9. PubMed ID: 11519041
[TBL] [Abstract][Full Text] [Related]
9. Methylation of the retinoid response gene TIG1 in prostate cancer correlates with methylation of the retinoic acid receptor beta gene.
Zhang J; Liu L; Pfeifer GP
Oncogene; 2004 Mar; 23(12):2241-9. PubMed ID: 14691453
[TBL] [Abstract][Full Text] [Related]
10. KRAB zinc-finger protein 382 regulates epithelial-mesenchymal transition and functions as a tumor suppressor, but is silenced by CpG methylation in gastric cancer.
Pei L; He X; Li S; Sun R; Xiang Q; Ren G; Xiang T
Int J Oncol; 2018 Sep; 53(3):961-972. PubMed ID: 29956735
[TBL] [Abstract][Full Text] [Related]
11. Demethylation of the synuclein gamma gene CpG island in primary gastric cancers and gastric cancer cell lines.
Yanagawa N; Tamura G; Honda T; Endoh M; Nishizuka S; Motoyama T
Clin Cancer Res; 2004 Apr; 10(7):2447-51. PubMed ID: 15073123
[TBL] [Abstract][Full Text] [Related]
12. Frequent epigenetic inactivation of RASSF1A in human bladder carcinoma.
Lee MG; Kim HY; Byun DS; Lee SJ; Lee CH; Kim JI; Chang SG; Chi SG
Cancer Res; 2001 Sep; 61(18):6688-92. PubMed ID: 11559536
[TBL] [Abstract][Full Text] [Related]
13. [Effects of DNA methylation on expression of TIG1 gene in acute leukemia].
Wang Y; Zhang JY; Lin FR; Niu ZY; Zhou JH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Jun; 22(3):648-52. PubMed ID: 24989270
[TBL] [Abstract][Full Text] [Related]
14. Aberrant TIG1 methylation associated with its decreased expression and clinicopathological significance in hepatocellular carcinoma.
Chen XH; Wu WG; Ding J
Tumour Biol; 2014 Feb; 35(2):967-71. PubMed ID: 24006221
[TBL] [Abstract][Full Text] [Related]
15. Frequent epigenetic inactivation of RIZ1 by promoter hypermethylation in human gastric carcinoma.
Oshimo Y; Oue N; Mitani Y; Nakayama H; Kitadai Y; Yoshida K; Chayama K; Yasui W
Int J Cancer; 2004 Jun; 110(2):212-8. PubMed ID: 15069684
[TBL] [Abstract][Full Text] [Related]
16. Aberrant methylation and silencing of the BNIP3 gene in colorectal and gastric cancer.
Murai M; Toyota M; Suzuki H; Satoh A; Sasaki Y; Akino K; Ueno M; Takahashi F; Kusano M; Mita H; Yanagihara K; Endo T; Hinoda Y; Tokino T; Imai K
Clin Cancer Res; 2005 Feb; 11(3):1021-7. PubMed ID: 15709167
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic down-regulation and suppressive role of DCBLD2 in gastric cancer cell proliferation and invasion.
Kim M; Lee KT; Jang HR; Kim JH; Noh SM; Song KS; Cho JS; Jeong HY; Kim SY; Yoo HS; Kim YS
Mol Cancer Res; 2008 Feb; 6(2):222-30. PubMed ID: 18314483
[TBL] [Abstract][Full Text] [Related]
18. [Aberrant promoter hypermethylation of tazarotine-induced gene 1 (TIG1) in head and neck cancer].
Tokumaru Y; Yahata Y; Fujii M
Nihon Jibiinkoka Gakkai Kaiho; 2005 Dec; 108(12):1152-7. PubMed ID: 16440812
[TBL] [Abstract][Full Text] [Related]
19. Tazarotene-induced gene 1 (TIG1) expression in prostate carcinomas and its relationship to tumorigenicity.
Jing C; El-Ghany MA; Beesley C; Foster CS; Rudland PS; Smith P; Ke Y
J Natl Cancer Inst; 2002 Apr; 94(7):482-90. PubMed ID: 11929948
[TBL] [Abstract][Full Text] [Related]
20. Discovery of epigenetically masked tumor suppressor genes in endometrial cancer.
Takai N; Kawamata N; Walsh CS; Gery S; Desmond JC; Whittaker S; Said JW; Popoviciu LM; Jones PA; Miyakawa I; Koeffler HP
Mol Cancer Res; 2005 May; 3(5):261-9. PubMed ID: 15886297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
